Serving hundreds of leading biopharmaceutical companies globally:

Generated: September 21, 2018

DrugPatentWatch Database Preview

RITUXAN Drug Profile

« Back to Dashboard

Summary for Tradename: RITUXAN

Patents:	472
Applicants:	1
BLAs:	1
Suppliers: see list	1
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for RITUXAN

Pharmacology for RITUXAN

Mechanism of Action	CD20-directed Antibody Interactions

US Patents for RITUXAN

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Genentech	RITUXAN	rituximab	VIAL	103705	001	1997-11-26	➤ Sign Up	SciClone Pharmaceuticals, Inc. (San Mateo, CA)	➤ Sign Up	RX		search
Genentech	RITUXAN	rituximab	VIAL	103705	001	1997-11-26	➤ Sign Up	Cytovia, Inc. (San Diego, CA)	➤ Sign Up	RX		search
Genentech	RITUXAN	rituximab	VIAL	103705	001	1997-11-26	➤ Sign Up	Merck & Co., Inc. (Rahway, NJ)	➤ Sign Up	RX		search
Genentech	RITUXAN	rituximab	VIAL	103705	001	1997-11-26	➤ Sign Up	BioMedicines, Inc. (Alameda, CA)	➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for RITUXAN

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Canada	2845806	➤ Sign Up
Taiwan	I337182	➤ Sign Up
Singapore	166093	➤ Sign Up
France	2924543	➤ Sign Up
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for RITUXAN

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2 50002-2015	Slovakia	➤ Sign Up	PRODUCT NAME: POMALIDOMID; REGISTRATION NO/DATE: EU/1/13/850/001 - EU/1/13/850/004 20130808
0717	Netherlands	➤ Sign Up	PRODUCT NAME: POMALIDOMIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN, SOLVATEN, HYDRATEN OF STEREOISOMEREN DAARVAN; REGISTRATION NO/DATE: EU/1/13/850 20130805
2017038	Lithuania	➤ Sign Up	PRODUCT NAME: SARILUMABAS; REGISTRATION NO/DATE: EU/1/17/1196 20170623
2017036	Lithuania	➤ Sign Up	PRODUCT NAME: INOTUZUMABO OZOGAMICINAS; REGISTRATION NO/DATE: EU/1/17/1200 20170629
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca

Covington

Queensland Health

Fish and Richardson

Express Scripts

Mallinckrodt

McKinsey

McKesson

Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.